LOCUS       NP_009297               1149 aa            linear   PRI 26-JUN-2007
DEFINITION  v-abl Abelson murine leukemia viral oncogene homolog 1 isoform b
            [Homo sapiens].
ACCESSION   NP_009297
VERSION     NP_009297.2  GI:62362412
DBSOURCE    REFSEQ: accession NM_007313.2
KEYWORDS    .
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 1149)
  AUTHORS   Jiang,X., Saw,K.M., Eaves,A. and Eaves,C.
  TITLE     Instability of BCR-ABL gene in primary and cultured chronic myeloid
            leukemia stem cells
  JOURNAL   J. Natl. Cancer Inst. 99 (9), 680-693 (2007)
   PUBMED   17470736
  REMARK    GeneRIF: Primary and cultured chronic myeloid leukemia stem
            cellsdisplay instability of the BCR-ABL fusion gene both in vivo
            and in vitro.
REFERENCE   2  (residues 1 to 1149)
  AUTHORS   Rodrigues,M.S. and Sattler,M.
  TITLE     Chronic myelogenous leukemia progenitors display a genetically
            unstable personality
  JOURNAL   J. Natl. Cancer Inst. 99 (9), 662-663 (2007)
   PUBMED   17470729
  REMARK    GeneRIF: Acute myelogenous leukemia patients respond to imatinib
            mesylate only when BCR-ABLE kinase is inhibited.
REFERENCE   3  (residues 1 to 1149)
  AUTHORS   Moller,G.M., Frost,V., Melo,J.V. and Chantry,A.
  TITLE     Upregulation of the TGFbeta signalling pathway by Bcr-Abl:
            implications for haemopoietic cell growth and chronic myeloid
            leukaemia
  JOURNAL   FEBS Lett. 581 (7), 1329-1334 (2007)
   PUBMED   17349636
  REMARK    GeneRIF: The expression of Bcr-Abl leads to hyper-responsiveness of
            myeloid cells to TGFbeta; this novel cross-regulatory mechanism
            might play an important role in maintaining the transformed
            progenitor cell population in CML.
REFERENCE   4  (residues 1 to 1149)
  AUTHORS   Sherbenou,D.W., Wong,M.J., Humayun,A., McGreevey,L.S., Harrell,P.,
            Yang,R., Mauro,M., Heinrich,M.C., Press,R.D., Druker,B.J. and
            Deininger,M.W.
  TITLE     Mutations of the BCR-ABL-kinase domain occur in a minority of
            patients with stable complete cytogenetic response to imatinib
  JOURNAL   Leukemia 21 (3), 489-493 (2007)
   PUBMED   17252009
  REMARK    GeneRIF: BCR-ABL-kinase domain mutations in patients with a stable
            CCR are infrequent, and their detection does not consistently
            predict relapse. Alternative mechanisms must be responsible for
            disease persistence in the majority of patients.
REFERENCE   5  (residues 1 to 1149)
  AUTHORS   Bartos,J.D., Gaile,D.P., McQuaid,D.E., Conroy,J.M., Darbary,H.,
            Nowak,N.J., Block,A., Petrelli,N.J., Mittelman,A., Stoler,D.L. and
            Anderson,G.R.
  TITLE     aCGH local copy number aberrations associated with overall copy
            number genomic instability in colorectal cancer: coordinate
            involvement of the regions including BCR and ABL
  JOURNAL   Mutat. Res. 615 (1-2), 1-11 (2007)
   PUBMED   17196995
  REMARK    GeneRIF: a system akin to the BCR-ABL translocation of CML may be
            involved in genomic instability in about one-third of colorectal
            carcinomas
REFERENCE   6  (residues 1 to 1149)
  AUTHORS   Overduin,M., Mayer,B., Rios,C.B., Baltimore,D. and Cowburn,D.
  TITLE     Secondary structure of Src homology 2 domain of c-Abl by
            heteronuclear NMR spectroscopy in solution
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 89 (24), 11673-11677 (1992)
   PUBMED   1281542
REFERENCE   7  (residues 1 to 1149)
  AUTHORS   Muller,A.J., Pendergast,A.M., Havlik,M.H., Puil,L., Pawson,T. and
            Witte,O.N.
  TITLE     A limited set of SH2 domains binds BCR through a high-affinity
            phosphotyrosine-independent interaction
  JOURNAL   Mol. Cell. Biol. 12 (11), 5087-5093 (1992)
   PUBMED   1383690
REFERENCE   8  (residues 1 to 1149)
  AUTHORS   Overduin,M., Rios,C.B., Mayer,B.J., Baltimore,D. and Cowburn,D.
  TITLE     Three-dimensional solution structure of the src homology 2 domain
            of c-abl
  JOURNAL   Cell 70 (4), 697-704 (1992)
   PUBMED   1505033
REFERENCE   9  (residues 1 to 1149)
  AUTHORS   Cicchetti,P., Mayer,B.J., Thiel,G. and Baltimore,D.
  TITLE     Identification of a protein that binds to the SH3 region of Abl and
            is similar to Bcr and GAP-rho
  JOURNAL   Science 257 (5071), 803-806 (1992)
   PUBMED   1379745
REFERENCE   10 (residues 1 to 1149)
  AUTHORS   Adams,M.D., Dubnick,M., Kerlavage,A.R., Moreno,R., Kelley,J.M.,
            Utterback,T.R., Nagle,J.W., Fields,C. and Venter,J.C.
  TITLE     Sequence identification of 2,375 human brain genes
  JOURNAL   Nature 355 (6361), 632-634 (1992)
   PUBMED   1538749
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from CA335983.1, AL707819.1,
            AB209456.1 and AA524892.1.
            On Apr 7, 2005 this sequence version replaced gi:6382058.
            
            Summary:  The ABL1 protooncogene encodes a cytoplasmic and nuclear
            protein tyrosine kinase that has been implicated in processes of
            cell differentiation, cell division, cell adhesion, and stress
            response.  Activity of c-Abl protein is negatively regulated by its
            SH3 domain, and deletion of the SH3 domain turns ABL1 into an
            oncogene.  The t(9;22) translocation results in the head-to-tail
            fusion of the BCR (MIM:151410) and ABL1 genes present in many cases
            of chronic myelogeneous leukemia.  The DNA-binding activity of the
            ubiquitously expressed ABL1 tyrosine kinase is regulated by
            CDC2-mediated phosphorylation, suggesting a cell cycle function for
            ABL1.  The ABL1 gene is expressed as either a 6- or 7-kb mRNA
            transcript, with alternatively spliced first exons spliced to the
            common exons 2-11.
            
            Transcript Variant:  Transcript variant b includes exon 1b, but not
            exon 1a, resulting in a different N-terminus. This variant contains
            an N-terminal glycine which could be myristylated and is thus
            postulated to be directed to the plasma membrane.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the
            Entrez Gene record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..1149
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="9"
                     /map="9q34.1"
     Protein         1..1149
                     /product="v-abl Abelson murine leukemia viral oncogene
                     homolog 1 isoform b"
                     /EC_number="2.7.10.1"
                     /note="Abelson murine leukemia viral (v-abl) oncogene
                     homolog 1; proto-oncogene tyrosine-protein kinase ABL1;
                     bcr/c-abl oncogene protein; BCR/ABL (major breakpoint)
                     fusion peptide; BCR-ABL fusion; BCR-ABL minor breakpoint
                     peptide"
                     /calculated_mol_wt=124824
     CDS             1..1149
                     /gene="ABL1"
                     /coded_by="NM_007313.2:440..3889"
                     /GO_component="nucleus [pmid 8242749]"
                     /GO_function="ATP binding; DNA binding [pmid 8242749];
                     nucleotide binding; protein C-terminus binding [pmid
                     11971963]; protein-tyrosine kinase activity [pmid
                     10391249]; transferase activity"
                     /GO_process="DNA damage response, signal transduction
                     resulting in induction of apoptosis [pmid 10391249];
                     intracellular signaling cascade; mismatch repair [pmid
                     10391249]; protein amino acid phosphorylation; regulation
                     of progression through cell cycle [pmid 8242749];
                     regulation of transcription, DNA-dependent [pmid 8242749];
                     S-phase-specific transcription in mitotic cell cycle [pmid
                     8242749]"
                     /note="isoform b is encoded by transcript variant b"
                     /db_xref="CCDS:CCDS35165.1"
                     /db_xref="GeneID:25"
                     /db_xref="HGNC:76"
                     /db_xref="HPRD:HPRD_01809"
                     /db_xref="MIM:189980"
ORIGIN      
        1 mgqqpgkvlg dqrrpslpal hfikgagkke ssrhggphcn vfvehealqr pvasdfepqg
       61 lseaarwnsk enllagpsen dpnlfvalyd fvasgdntls itkgeklrvl gynhngewce
      121 aqtkngqgwv psnyitpvns lekhswyhgp vsrnaaeyll ssgingsflv resesspgqr
      181 sislryegrv yhyrintasd gklyvssesr fntlaelvhh hstvadglit tlhypapkrn
      241 kptvygvspn ydkwemertd itmkhklggg qygevyegvw kkysltvavk tlkedtmeve
      301 eflkeaavmk eikhpnlvql lgvctreppf yiitefmtyg nlldylrecn rqevnavvll
      361 ymatqissam eylekknfih rdlaarnclv genhlvkvad fglsrlmtgd tytahagakf
      421 pikwtapesl aynkfsiksd vwafgvllwe iatygmspyp gidlsqvyel lekdyrmerp
      481 egcpekvyel mracwqwnps drpsfaeihq afetmfqess isdevekelg kqgvrgavst
      541 llqapelptk trtsrraaeh rdttdvpemp hskgqgesdp ldhepavspl lprkergppe
      601 gglnederll pkdkktnlfs alikkkkkta ptppkrsssf remdgqperr gageeegrdi
      661 sngalaftpl dtadpakspk psngagvpng alresggsgf rsphlwkkss tltssrlatg
      721 eeegggsssk rflrscsasc vphgakdtew rsvtlprdlq stgrqfdsst fgghksekpa
      781 lprkragenr sdqvtrgtvt ppprlvkkne eaadevfkdi messpgsspp nltpkplrrq
      841 vtvapasglp hkeeagkgsa lgtpaaaepv tptskagsga pggtskgpae esrvrrhkhs
      901 sespgrdkgk lsrlkpappp ppaasagkag gkpsqspsqe aageavlgak tkatslvdav
      961 nsdaakpsqp geglkkpvlp atpkpqsakp sgtpispapv pstlpsassa lagdqpssta
     1021 fiplistrvs lrktrqpper iasgaitkgv vldstealcl aisrnseqma shsavleagk
     1081 nlytfcvsyv dsiqqmrnkf afreainkle nnlrelqicp atagsgpaat qdfskllssv
     1141 keisdivqr
//

